Last reviewed · How we verify
Lactobacillus fermentum LC40 — Competitive Intelligence Brief
phase 2
Biologic
Live · refreshed every 30 min
Target snapshot
Lactobacillus fermentum LC40 (Lactobacillus fermentum LC40) — Universidad Complutense de Madrid.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Lactobacillus fermentum LC40 TARGET | Lactobacillus fermentum LC40 | Universidad Complutense de Madrid | phase 2 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Lactobacillus fermentum LC40 CI watch — RSS
- Lactobacillus fermentum LC40 CI watch — Atom
- Lactobacillus fermentum LC40 CI watch — JSON
- Lactobacillus fermentum LC40 alone — RSS
Cite this brief
Drug Landscape (2026). Lactobacillus fermentum LC40 — Competitive Intelligence Brief. https://druglandscape.com/ci/lactobacillus-fermentum-lc40. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab